Direct correlation between regional systolic function and regional washout rate of 99mTc-sestamibi in patients with idiopathic dilated cardiomyopathy

Nuclear Medicine Communications

Volumn 32, Issue 12, 2011, Pages 1174-1178

  Takehana, Kazuya ^a   Maeba, Hirofumi ^a   Ueyama, Takanao ^a   Iwasaka, Toshiji ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

99mTc sestamibi; nonischemic dilated cardiomyopathy; regional washout rate

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; DRUG CLEARANCE; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; FEMALE; GATED BLOOD-POOL IMAGING; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; SYSTOLE; TECHNETIUM TC 99M SESTAMIBI; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR DYSFUNCTION, LEFT;

EID: 80455168274     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32834b60be     Document Type: Article

References (22)

1. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994; 331:1564-1575.
2. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation 1990; 82:1826-1838.
3. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. J Nucl Med 1990; 31:1646-1653.
4. Okada R, Glover D, Gaffney T, Williams S. Myocardial kinetics of techenetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 1988; 77:491-498.
5. Wackers FJ, Berman DS, Maddahi J, Watson DD, Beller GA, Straus HW, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989; 30:301-311.
6. Beller G, Watson D. Physiological basis of myocardial perfusion imaging with the technetium agents. Semin Nucl Med 1991; 21:173-181.
7. Takeishi Y, Sukekawa H, Fujiwara S, Ikeno E, Sasaki Y, Tomoike H. Reverse redistribution of technetium-99m-sestamibi following direct PTCA in acute myocardial infarction. J Nucl Med 1996; 37:1289-1294.
8. Fujiwara S, Takeishi Y, Atsumi H, Yamaki M, Takahashi N, Yamaoka M, et al. Prediction of functional recovery in acute myocardial infarction: comparison between sestamibi reverse redistribution and sestamibi/BMIPP mismatch. J Nucl Cardiol 1998; 5:119-127.
9. Fujiwara S, Takeishi Y, Hirono O, Fukui A, Okuyama M, Yamaguchi S, et al. Reverse redistribution of 99mTc-sestamibi after direct percutaneous transluminal coronary angioplasty in acute myocardial infarction: relationship with wall motion and functional response to dobutamine stimulation. Nucl Med Commun 2001; 22:1223-1230.
10. Kumita S, Seino Y, Cho K, Nakajo H, Toba M, Fukushima Y, et al. Assessment of myocardial washout of Tc-99m-sestamibi in patients with chronic heart failure: comparison with normal control. Ann Nucl Med 2002; 16:237-242.
11. Sugiura T, Takase H, Toriyama T, Goto T, Ueda R, Dohi Y. Usefulness of Tc-99m methoxyisobutylisonitrile scintigraphy for evaluating congestive heart failure. J Nucl Cardiol 2006; 13:64-68.
12. Liu Z, Johnson G 3rd, Beju D, Okada RD. Detection of myocardial viability in ischemic-reperfused rat hearts by Tc-99m sestamibi kinetics. J Nucl Cardiol 2001; 8:677-686.
13. Matsuo S, Nakae I, Tsutamoto T, Okamoto N, Horie M. A novel clinical indicator using Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathy. J Nucl Cardiol 2007; 14: 215-220.
14. Unno K, Isobe S, Izawa H, Cheng XW, Kobayashi M, Hirashiki A, et al. Relation of functional and morphological changes in mitochondria to myocardial contractile and relaxation reserves in asymptomatic to mildly symptomatic patients with hypertrophic cardiomyopathy. Eur Heart J 2009; 30:1853-1862.
15. Nakae I, Matsuo S, Koh T, Mitsunami K, Horie M. Left ventricular systolic/ diastolic function evaluated by quantitative ECG-gated SPECT: comparison with echocardiography and plasma BNP analysis. Ann Nucl Med 2005; 19:447-454.
16. Slomka PJ, Nishina H, Berman DS, Kang X, Friedman JD, Hayes SW, et al. Automatic quantification of myocardial perfusion stress-rest change: a new measure of ischemia. J Nucl Med 2004; 45:183-191.
17. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995; 36:2138-2147.
18. Crane P, Laliberté R, Heminway S, Thoolen M, Orlandi C. Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention. Eur J Nucl Med 1993; 20:20-25.
19. Caner B, Beller GA. Are 99mTc labeled myocardial perfusion agents adequate for detection of myocardial viability? Clin Cardiol 1998; 21:235-242.
20. Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL, et al. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 1992; 33:1516-1522.
21. Arbustini E, Diegoli M, Fasani R, Grasso M, Mirbini P, Banchieri N, et al. Mitochodrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol 1998; 153:1501-1510.
22. Rupport V, Maisch B, Mitochondrial DNA. deletions in cardiomyopathies. Herz 2000; 25:161-167.